Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein 76 (CEP76) is a centriolar protein that interacts with proteins such as CP110 and Cep97 and is localized to the centrosome. Its principal role is to serve as a negative regulator of centrosome duplication by ensuring that centriole duplication occurs only once per cell cycle. CEP76 expression is low in the G1 phase, increases in the S and G2 phases, and is tightly regulated at the post-translational level by phosphorylation. Loss of CEP76 function can lead to centriole overduplication and is observed to affect only specific cell types, such as certain cancer cells. CEP76 involvement has been observed in cancer and some neurodegenerative disorders, although no direct drug interactions or therapeutic targeting have been reported for this protein to date[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein 76 (CEP76).